At present, several gene expression analyses targeting tumor biopsy tissue are underway, and the human SHARPIN gene is upregulated in tumorigenesis in various human cancers such as breast cancer, esophageal cancer and renal cell carcinoma (Table 1) (96–98). The gene discussed is SHARPIN; the disease is breast carcinoma.